BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33989513)

  • 1. Bipartite binding of the N terminus of Skp2 to cyclin A.
    Kelso S; Orlicky S; Beenstock J; Ceccarelli DF; Kurinov I; Gish G; Sicheri F
    Structure; 2021 Sep; 29(9):975-988.e5. PubMed ID: 33989513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminative SKP2 Interactions with CDK-Cyclin Complexes Support a Cyclin A-Specific Role in p27KIP1 Degradation.
    Salamina M; Montefiore BC; Liu M; Wood DJ; Heath R; Ault JR; Wang LZ; Korolchuk S; Baslé A; Pastok MW; Reeks J; Tatum NJ; Sobott F; Arold ST; Pagano M; Noble MEM; Endicott JA
    J Mol Biol; 2021 Mar; 433(5):166795. PubMed ID: 33422522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrate recognition and ubiquitination of SCFSkp2/Cks1 ubiquitin-protein isopeptide ligase.
    Xu S; Abbasian M; Patel P; Jensen-Pergakes K; Lombardo CR; Cathers BE; Xie W; Mercurio F; Pagano M; Giegel D; Cox S
    J Biol Chem; 2007 May; 282(21):15462-70. PubMed ID: 17409098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryo-EM structure of SKP1-SKP2-CKS1 in complex with CDK2-cyclin A-p27KIP1.
    Rowland RJ; Heath R; Maskell D; Thompson RF; Ranson NA; Blaza JN; Endicott JA; Noble MEM; Salamina M
    Sci Rep; 2023 Jul; 13(1):10718. PubMed ID: 37400515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skp2 contains a novel cyclin A binding domain that directly protects cyclin A from inhibition by p27Kip1.
    Ji P; Goldin L; Ren H; Sun D; Guardavaccaro D; Pagano M; Zhu L
    J Biol Chem; 2006 Aug; 281(33):24058-69. PubMed ID: 16774918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitination of p27Kip1 requires physical interaction with cyclin E and probable phosphate recognition by SKP2.
    Ungermannova D; Gao Y; Liu X
    J Biol Chem; 2005 Aug; 280(34):30301-9. PubMed ID: 15980415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquitination of p21Cip1/WAF1 by SCFSkp2: substrate requirement and ubiquitination site selection.
    Wang W; Nacusi L; Sheaff RJ; Liu X
    Biochemistry; 2005 Nov; 44(44):14553-64. PubMed ID: 16262255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis of the Cks1-dependent recognition of p27(Kip1) by the SCF(Skp2) ubiquitin ligase.
    Hao B; Zheng N; Schulman BA; Wu G; Miller JJ; Pagano M; Pavletich NP
    Mol Cell; 2005 Oct; 20(1):9-19. PubMed ID: 16209941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanoma antigen-A11 regulates substrate-specificity of Skp2-mediated protein degradation.
    Su S; Chen X; Geng J; Minges JT; Grossman G; Wilson EM
    Mol Cell Endocrinol; 2017 Jan; 439():1-9. PubMed ID: 27720894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disrupting Skp2-cyclin A interaction with a blocking peptide induces selective cancer cell killing.
    Ji P; Sun D; Wang H; Bauzon F; Zhu L
    Mol Cancer Ther; 2007 Feb; 6(2):684-91. PubMed ID: 17308064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skp2-Cyclin A Interaction Is Necessary for Mitotic Entry and Maintenance of Diploidy.
    Vasavan B; Das N; Kahnamouei P; Trombley C; Swan A
    J Mol Biol; 2024 Apr; 436(8):168505. PubMed ID: 38423454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin-dependent kinases phosphorylate human Cdt1 and induce its degradation.
    Liu E; Li X; Yan F; Zhao Q; Wu X
    J Biol Chem; 2004 Apr; 279(17):17283-8. PubMed ID: 15004027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three different binding sites of Cks1 are required for p27-ubiquitin ligation.
    Sitry D; Seeliger MA; Ko TK; Ganoth D; Breward SE; Itzhaki LS; Pagano M; Hershko A
    J Biol Chem; 2002 Nov; 277(44):42233-40. PubMed ID: 12140288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of human CUL-1 and ubiquitin-conjugating enzyme CDC34 with the F-box protein p45(SKP2): evidence for evolutionary conservation in the subunit composition of the CDC34-SCF pathway.
    Lisztwan J; Marti A; Sutterlüty H; Gstaiger M; Wirbelauer C; Krek W
    EMBO J; 1998 Jan; 17(2):368-83. PubMed ID: 9430629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase.
    Bashir T; Dorrello NV; Amador V; Guardavaccaro D; Pagano M
    Nature; 2004 Mar; 428(6979):190-3. PubMed ID: 15014502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noncatalytic requirement for cyclin A-cdk2 in p27 turnover.
    Zhu XH; Nguyen H; Halicka HD; Traganos F; Koff A
    Mol Cell Biol; 2004 Jul; 24(13):6058-66. PubMed ID: 15199159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin B and cyclin A confer different substrate recognition properties on CDK2.
    Brown NR; Lowe ED; Petri E; Skamnaki V; Antrobus R; Johnson LN
    Cell Cycle; 2007 Jun; 6(11):1350-9. PubMed ID: 17495531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27(KIP1) through the ubiquitin E3 ligase SCF(SKP2).
    Mamillapalli R; Gavrilova N; Mihaylova VT; Tsvetkov LM; Wu H; Zhang H; Sun H
    Curr Biol; 2001 Feb; 11(4):263-7. PubMed ID: 11250155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of neddylation and deneddylation of cullin1 in SCFSkp2 ubiquitin ligase by F-box protein and substrate.
    Bornstein G; Ganoth D; Hershko A
    Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11515-20. PubMed ID: 16861300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Rb-Skp2-p27 pathway mediates acute cell cycle inhibition by Rb and is retained in a partial-penetrance Rb mutant.
    Ji P; Jiang H; Rekhtman K; Bloom J; Ichetovkin M; Pagano M; Zhu L
    Mol Cell; 2004 Oct; 16(1):47-58. PubMed ID: 15469821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.